• 1
    Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992; 15: 21122.
  • 2
    Haverkos HW, The TE study group. Assessment of therapy for toxoplasma encephalitis. Am J Med 1987; 82: 90714.
  • 3
    Alder J, Hutch T, Meulbroek JA, Clement JC. Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine. J AIDS 1994; 7: 11418.
  • 4
    Romand S, Bryskier A, Moutot M, Derouin F. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulfadiazine against Toxoplasma gondii. J Antimicrob Chemother 1995; 35: 82132.
  • 5
    Araujo FG, Huskinson J, Remington JS. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone, 566C80, against tachyzoites and tissue cysts of Toxoplasma gondii. Antimicrob Agents Chemother 1991; 35: 2939.
  • 6
    Huskinson J, Araujo FG, Remington JS. Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. J Infect Dis 1991; 164: 1707.
  • 7
    Tabbara KF, Nozik RA, O'Connor GR. Clindamycin effects on experimental ocular toxoplasmosis in the rabbit. Arch Ophthalmol 1974; 92: 2447.
  • 8
    Engstrom RE Jr, Holland GN, Nussenblatt RB, Jabs DA. Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 1991; 111: 60110.
  • 9
    Djurkovic-Djakovic O, Stanojevic-Paovic A, Bobic B, et al. Short-term effects of the clindamycin-steroid regimen in the treatment of ocular toxoplasmosis. J Chemother 1995; 7 (suppl 4): S199201.
  • 10
    Katlama C. Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS. Eur J Clin Microbiol Infect Dis 1991; 10: 18991.
  • 11
    Dannemann B, McCutchan JA, Israelski D, et al. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. Ann Intern Med 1992; 116: 3343.
  • 12
    Renold C, Sugar A, Chave J, et al. Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Medicine 1992; 71: 22439.
  • 13
    Araujo FG, Remington JS. Effect of clindamycin on acute and chronic toxoplasmosis in mice. Antimicrob Agents Chemother 1974; 5: 64751.
  • 14
    Hofflin JM, Remington JS. Clindamycin in a murine model of toxoplasmic encephalitis. Antimicrob Agents Chemother 1987; 31: 4926.
  • 15
    Garin JP, Paillard B. Toxoplasmose expérimentale de la souris. Activité comparée de: clindamycine, midécamycine, josamycine, spiramycine, pyriméthamine-sulfadoxine, et triméthoprime-sulfaméthoxazole. Ann Pediatr 1984; 31: 8415.
  • 16
    Piketty C, Dérouin F, Rouveix B, Pocidalo J. In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice. Antimicrob Agents Chemother 1990; 34: 146772.
  • 17
    Pfefferkorn ER, Nothnagel RF, Borotz SE. Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant. Antimicrob Agents Chemother 1992; 36: 10916.
  • 18
    Fichera ME, Bhopale MK, Roos DS. In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii. Antimicrob Agents Chemother 1995; 39: 15307.
  • 19
    Eyles DE, Coleman N. Notes on the treatment of acute experimental toxoplasmosis of the mouse with chlortetra-cycline and tetracycline. Antibiot Chemother 1956; 4: 98891.
  • 20
    Frenkel JK. Host, strain and treatment variation as factors in the pathogenesis of toxoplasmosis. Am J Trop Med Hyg 1953; 2: 390411.
  • 21
    Lecomte V, Chumpitazi BFF, Pasquier B, et al. Brain-tissue cysts in rats infected with the RH strain of Toxoplasma gondii. Parasitol Res 1992; 78: 2679.
  • 22
    Sternberger LA. Immunohistochemistry, 3rd edn. New York : Wiley, 1986.
  • 23
    McMaster PRB, Powers KG, Finerty JF, Lunde MN. The effect of two chlorinated lincomycin analogues against acute toxoplasmosis in mice. Am J Trop Med Hyg 1973; 22: 1417.